Table 2.
BLM To Control | BLM+P21 To BLM | BLM+P28 To BLM | P21 To Control | P28 To Control | |
---|---|---|---|---|---|
Col1a1 | ↑ | ↑ | ↔ | ↑ | ↑ |
Col1a2 | ↑ | ↔ | ↓ | ↑ | ↑ |
α- SMA | ↑ | ↔ | ↑ | ↔ | ↑ |
TGF-β | ↑ | ↔ | ↑ | ↔ | ↑ |
Ctgf | ↔ | ↑ | ↓ | ↔ | ↓ |
Edn1 | ↔ | ↔ | ↓ | ↔ | ↔ |
Mast cell | ↔ | ↔ | ↔ | ↔ | ↔ |
MMP9 | ↑⁎ | ↔ | ↓ | ↔ | ↔ |
MMP2 | ↔⁎ | ↔ | ↔ | ↔ | ↔ |
TNF-α | ↑ | ↓ | ↓ | ↔ | ↔ |
Cortisol | ↓ | ↔ | ↑ | ↔ | ↔ |
Collagen | ↑ | ↔ | ↑ | ↑ | ↑ |
Apoptosis⁎ | ↑ | ↔ | ↔ | ↔ | ↔ |
Fibrosis | ↑ | ↔ | ↑ | ↑ | ↑ |
P, Progesterone; BLM, Bleomycin; Col1a1, Collagen Type I Alpha 1 Chain gene; Col1a2, Collagen Type I Alpha 2 Chain gene; α-SMA, Alpha smooth muscle actin; Ctgf, connective tissue growth factor gene; Edn1, Endothelin -1 gene; MMP9, Matrix metalloproteinase 9; MMP2, Matrix metalloproteinase 2. ↑ = increased, ↓ = decreased, ↔ = does not alter. ⁎ = results adapted from references (4) and (5).